|
Dr. Berendt, Ph.D., 58, has served as a Director of the Company since March 1998. Dr. Berendt is the President and Chief Executive Officer of Aegera Therapeutics, Inc., a position he assumed in March 2006. From August 2004 to March 2006, Dr. Berendt served as a Managing Director of Research Corporation Technologies. From November 2000 to August 2004, Dr. Berendt served as Managing Director, Life Sciences Group, AEA Investors Inc. Prior to joining AEA, Dr. Berendt worked for 18 years in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation and as Group Director of Drug Discovery at Pfizer, Inc. where he was responsible for immunology, pulmonary, inflammation, and antibiotic research. Dr. Berendt has served as a member of the Board of Directors of Myriad Genetics, Inc. and Onyx Pharmaceuticals, Inc., Catalyst Biosciences and Northstar Neuroscience. | 